NIH-funded research R01 grant

Metabolomics in ICH recovery to help understand outcomes

Official title: Metabolomics of ICH recovery (METABOL-ICH)

Funded at University of Cincinnati · NIH-11362207 · Data updated 2026-11-12

A study using blood samples from stroke patients who had brain hemorrhages to find metabolic patterns linked to recovery, with a focus on Black and Hispanic communities.

More Metabolomics research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMay 15, 2025
Project endApril 30, 2029
Funding year2026
Award (this year)$634,454
NIH project number5R01NS140155-02
Project IDNIH-11362207 on NIH RePORTER

Who could benefit from this research

Could help

Adults who experienced intracerebral hemorrhage, with emphasis on Black and Hispanic individuals, and matched controls with available plasma samples.

Less likely to help

Patients without ICH or those without available samples or 90-day outcome data may not directly benefit.

What this research studies

This project will analyze metabolic profiles from stored samples of ICH patients and matched controls to identify biomarkers associated with poor outcomes. It uses a comprehensive metabolomics approach on data from diverse cohorts (ERICH and ROSE) to uncover pathways involved in recovery. The findings could point to new targets for therapies that improve recovery after intracerebral hemorrhage. The work builds on existing patient data, with careful attention to race/ethnicity and geographic representation. Participants’ data come from multiple sites across the United States and include clinical and imaging information.

Why it matters

Potential benefit: If successful, the research could lead to new metabolic targets for therapies that improve recovery after brain hemorrhage, potentially reducing disability.

How similar studies have gone: Previous metabolomic studies in stroke have identified meaningful biomarkers; this project extends those findings to diverse populations with a large, well-characterized sample set.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Demel, Stacie — University of Cincinnati
  • Study coordinator: Demel, Stacie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.